End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.43 USD | +6.06% |
|
+3.24% | -51.62% |
Jul. 02 | Gyre Wins China Approval for Tablet to Treat Thrombocytopenia | DJ |
Jul. 02 | Gyre Therapeutics Low Blood Platelet Treatment Approved in China | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-51.62% | 1.06B | |
+17.09% | 45.34B | |
+42.10% | 40.42B | |
-9.70% | 37.92B | |
+33.28% | 31.75B | |
-8.98% | 27.71B | |
+13.37% | 26.52B | |
+44.11% | 13.96B | |
+32.33% | 12.44B | |
-7.26% | 11.26B |
- Stock Market
- Equities
- GYRE Stock
- News Gyre Therapeutics, Inc.
- Gyre Therapeutics Insider Sold Shares Worth $323,000, According to a Recent SEC Filing